Publication Name	World Journal of Transplantation
Manuscript ID	118249
Country	India

Category	Transplantation
Manuscript Type	Retrospective Study
Article Title	Efficacy and safety of low-dose everolimus and tacrolimus in kidney transplant recipients: A retrospective study
Manuscript Source	Invited Manuscript
All Author List	Dilip Kumar Pahari and Hirak Pahari
Funding Agency and Grant Number
Corresponding Author	Hirak Pahari, MD, Department of Liver Transplant and Hepatobiliary Surgery, Medica Superspeciality Hospital, Mukundapur, Kolkata 700099, West Bengal, India. hirak.pahari@gmail.com
Key Words	Mammalian target of rapamycin inhibitors; Everolimus; Calcineurin inhibitors; Immunosuppression; Graft rejection; Kidney transplant
Core Tip	The use of combination of low dose tacrolimus and everolimus is not common in kidney transplant recipients. We show in our study that the combination therapy with everolimus (low dose) + tacrolimus (Tac) (low dose) as compared to mycophenolate mofetil + Tac is found to be superior in terms of lower incidence of side effects and stable serum creatinine levels over long-term follow-up.
Citation	Pahari DK, Pahari H. Efficacy and safety of low-dose everolimus and tacrolimus in kidney transplant recipients: A retrospective study. World J Transplant 2026; In press

Received	2025-12-28 14:18
Peer-Review Started	2025-12-28 14:19
First Decision by Editorial Office Director	2025-12-31 08:25
Return for Revision	2025-12-31 08:25
Revised	2026-03-15 19:47
Publication Fee Transferred
Second Decision by Editor	2026-04-01 02:39
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-04-01 10:04
Articles in Press	2026-04-01 10:04
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2220-3230 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com